Quantum
Home > Boards > US Listed > Biotechs > Neurotrope Inc. (NTRP)

Sitting on 7.02 average sometimes I'm wrong but

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Whoopddew Member Profile
 
Followed By 0
Posts 187
Boards Moderated 0
Alias Born 01/14/18
160x600 placeholder
Quarterly Report (10-q) Edgar (US Regulatory) - 10/30/2018 5:04:21 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 10/24/2018 4:10:15 PM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 10/24/2018 4:08:04 PM
Neurotrope Presents Updated Phase 2 Data of Bryostatin-1 in Moderate to Severe Alzheimer's Disease at the 11th Edition of CTA... PR Newswire (US) - 10/24/2018 8:30:00 AM
Neurotrope to Present at the Ladenburg Thalmann 2018 Healthcare Conference PR Newswire (US) - 9/27/2018 8:30:00 AM
Neurotrope to Present Additional Phase 2 Data at the 11th Edition of Clinical Trials on Alzheimer's Disease (CTAD2018) PR Newswire (US) - 9/26/2018 8:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/5/2018 5:03:00 PM
Neurotrope Enters into Collaboration with the Nemours / Alfred I. duPont Hospital for Children to Initiate a Clinical Trial i... PR Newswire (US) - 9/5/2018 8:30:00 AM
Neurotrope Announces Participation at the 20th Annual Rodman & Renshaw Global Investment Conference in New York City Septembe... PR Newswire (US) - 8/28/2018 8:30:00 AM
Neurotrope Provides Business Update and Reports Second Quarter 2018 Financial Results PR Newswire (US) - 8/13/2018 8:30:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/10/2018 5:16:18 PM
At AAIC 2018, Neurotrope Presents Additional Clinical Results Showing Cognitive Improvement in Phase 2 Data Assessing Bryosta... PR Newswire (US) - 7/25/2018 8:30:00 AM
Neurotrope Announces the Initiation of Enrollment of its Confirmatory Phase 2 Trial in Alzheimer's Disease PR Newswire (US) - 7/16/2018 8:30:00 AM
Neurotrope Appoints Leading Experts in Alzheimer's Disease to its Scientific Advisory Board (SAB) PR Newswire (US) - 7/11/2018 8:30:00 AM
Neurotrope to Present Additional Phase 2 Data at the Alzheimer's Association International Conference (AAIC) 2018 Meeting PR Newswire (US) - 7/2/2018 8:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/22/2018 4:33:07 PM
Confidential Treatment Order (ct Order) Edgar (US Regulatory) - 6/6/2018 10:46:12 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/14/2018 5:19:46 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/10/2018 5:26:45 PM
Neurotrope, In Consultation With Leading Neuroscientists, Completes the Study Design for its Confirmatory Phase 2 Trial in Ad... PR Newswire (US) - 5/7/2018 8:30:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/16/2018 4:07:39 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/15/2018 5:10:27 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/15/2018 5:10:27 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/15/2018 5:10:02 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/15/2018 5:10:02 PM
Whoopddew   Friday, 02/09/18 05:36:06 PM
Re: runncoach post# 5730
Post # of 7287 
Sitting on 7.02 average sometimes I'm wrong but I feel really good on this one

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist